News

Upper GI cancer treatment depends on a number of factors, and may include treatments such as surgery, chemotherapy, radiation ...
With darting red and green beams above me and large mechanical eyes and grids humming and moving around me, I feel as though I’m in a 1950s sci-fi movie.
A phase 2 trial reveals that combining intratumoral BO-112 with pembrolizumab shows potential in treating anti–PD-1-resistant ...
I’ve endured numerous rounds of radiation and taken thousands of pills—but CAR-T is the most effective therapy I’ve completed ...
A Cedar Rapids-based home-health agency accused of using falsified records and billing for care services that were never ...
As of the last update from the U.S. Centers for Disease Control and Prevention, on June 30, the salmonella outbreak linked to ...
KFSHRC Treats Rare Disease After 22 Years of Specialized CareRIYADH, Saudi Arabia, July 09, 2025 (GLOBE NEWSWIRE) -- In a rare example of a lifelong bond between a patient and a healthcare institution ...
Eight individuals connected to the children's abnormal blood lead case at a kindergarten in Tianshui city, Northwest China's ...
During a live event, Jeffrey V. Matous, MD, discussed bispecific antibody treatment efficacy and safety in advanced multiple ...
Ultragenyx Pharmaceutical Inc. shares plunged 30% as UX143 trial raises efficacy doubts. Click for more on RARE and my ...
The disease primarily affects middle-aged women and has a poor long-term prognosis despite therapeutic advances.
Mesoblast shows promise with FDA progress and a strong pipeline, but limited data and execution risks persist. Learn why MESO ...